K+S Aktiengesellschaft (ETR:SDF – Get Rating) has been given a €38.00 ($38.00) price target by equities research analysts at JPMorgan Chase & Co. in a research report issued on Thursday, Borsen Zeitung reports. JPMorgan Chase & Co.‘s price objective suggests a potential upside of 79.16% from the stock’s current price.
A number of other analysts have also weighed in on the company. UBS Group set a €21.00 ($21.00) target price on K+S Aktiengesellschaft in a report on Thursday. Berenberg Bank set a €23.00 ($23.00) price objective on K+S Aktiengesellschaft in a report on Friday, August 12th. Deutsche Bank Aktiengesellschaft set a €37.00 ($37.00) price objective on K+S Aktiengesellschaft in a report on Friday, August 12th. Baader Bank set a €27.00 ($27.00) price objective on K+S Aktiengesellschaft in a report on Thursday. Finally, Warburg Research set a €29.00 ($29.00) price objective on K+S Aktiengesellschaft in a report on Thursday.
K+S Aktiengesellschaft Stock Down 2.5 %
K+S Aktiengesellschaft stock opened at €21.21 ($21.21) on Thursday. The business has a fifty day moving average of €21.31 and a two-hundred day moving average of €23.34. The company has a quick ratio of 1.22, a current ratio of 1.73 and a debt-to-equity ratio of 17.30. The firm has a market cap of $4.06 billion and a P/E ratio of 1.65. K+S Aktiengesellschaft has a twelve month low of €13.41 ($13.41) and a twelve month high of €36.45 ($36.45).
K+S Aktiengesellschaft Company Profile
K+S Aktiengesellschaft, together with its subsidiaries, operates as a supplier of mineral products for the agricultural, industrial, consumer, and community segments worldwide. It operates through Agriculture, and Industry+ segments. The Agriculture segment offers potassium chloride for important crops, such as cereals, corn, rice, and soybeans; and fertilizer specialties that are used for crops for magnesium and sulfur, including rapeseed or potatoes, as well as for chloride-sensitive crops consisting of citrus fruits, grapes, or vegetables.
- MarketBeat: Week in Review 11/7 – 11/11
- Oil Is a Compelling Reason The Sell-Off In Stocks Isn’t Over
- Is Mid-Cap Neurocrine Biosciences A Buy After Blowout Q3 Report?
- Six Flags is a Ride You Don’t Want to Get Stuck On
- Vision Hydrogen, Now Vision Energy, Puts Hopes In Stock Split
Receive News & Ratings for K+S Aktiengesellschaft Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for K+S Aktiengesellschaft and related companies with MarketBeat.com's FREE daily email newsletter.